Home > Organic Chemicals

17,21-dihydroxy-16alpha-methylpregna-1,4,9(11)-triene-3,20-dione

  • Name: 17,21-dihydroxy-16alpha-methylpregna-1,4,9(11)-triene-3,20-dione
  • CAS: 13209-41-1
  • Purity: 99%
Send Inquiry
  • Description

    Reputable factory supply 17,21-dihydroxy-16alpha-methylpregna-1,4,9(11)-triene-3,20-dione 13209-41-1 in bulk at low price

    • Molecular Formula: C22H28 O4
    • Molecular Weight: 356.462
    • Vapor Pressure: 2.63E-14mmHg at 25°C 
    • Melting Point: 228-231 °C(Solv: acetone (67-64-1); hexane (110-54-3)) 
    • Boiling Point: 548.3°C at 760 mmHg 
    • PKA: 12.53±0.70(Predicted) 
    • Flash Point: 299.4°C 
    • PSA： 74.60000 
    • Density: 1.24g/cm3 
    • LogP: 2.75290 

    17,21-dihydroxy-16alpha-methylpregna-1,4,9(11)-triene-3,20-dione(Cas 13209-41-1) Usage

    InChI:InChI=1/C22H28O4/c1-13-10-18-16-5-4-14-11-15(24)6-8-20(14,2)17(16)7-9-21(18,3)22(13,26)19(25)12-23/h6-8,11,13,16,18,23,26H,4-5,9-10,12H2,1-3H3/t13-,16-,18+,20+,21+,22+/m1/s1

    13209-41-1 Relevant articles

    AQUEOUS ORAL PHARMACEUTICAL SUSPENSION COMPOSITIONS

    -

    Paragraph 0124; 0131, (2020/09/22)

    Provided is an aqueous oral pharmaceutic...

    Non-hormonal steroid modulators of NF-κβ for treatment of disease

    -

    Page/Page column 42-43; 44, (2019/11/18)

    The present invention relates to compoun...

    A 17, 21 - double-hydroxy steroid derivatives

    -

    Paragraph 0079-0081; 0100-0101, (2018/04/02)

    The invention relates to a method for pr...

    VBP15: Preclinical characterization of a novel anti-inflammatory delta 9,11 steroid

    Reeves, Erica K.M.,Hoffman, Eric P.,Nagaraju, Kanneboyina,Damsker, Jesse M.,McCall, John M.

    , p. 2241 - 2249 (2013/05/22)

    Δ9,11 modifications of glucocorticoids (...

    13209-41-1 Process route

    C<sub>25</sub>H<sub>36</sub>O<sub>4</sub>Si

    C25 H36 O4 Si

    (8S,10S,13S,14S,16R,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-one
    13209-41-1

    (8S,10S,13S,14S,16R,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-one

    Conditions
    Conditions Yield
    With hydrogenchloride; In pentan-1-ol;
    		80%
    17α,21-dihydroxy-16α-methyl-1,4,9(11)-pregnatriene-3,20-dione 21-acetate
    10106-41-9

    17α,21-dihydroxy-16α-methyl-1,4,9(11)-pregnatriene-3,20-dione 21-acetate

    (8S,10S,13S,14S,16R,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-one
    13209-41-1

    (8S,10S,13S,14S,16R,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-one

    Conditions
    Conditions Yield
    With water; potassium carbonate; In methanol; at 0 - 20 ℃;

    13209-41-1 Upstream products

    • 37413-91-5
      37413-91-5

      2-((10S,13S)-10,13-dimethyl-3-oxo-6,7,8,10,12,13,14,15-octahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate

    • 910-99-6
      910-99-6

      2-((10S,13S,16R,17R)-17-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate

    • 37413-91-5
      37413-91-5

      2-((10S,13S,14S)-10,13-dimethyl-3-oxo-6,7,8,10,12,13,14,15-octahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate

    • 10106-41-9
      10106-41-9

      17α,21-dihydroxy-16α-methyl-1,4,9(11)-pregnatriene-3,20-dione 21-acetate

    13209-41-1 Downstream products

    • 151265-36-0
      151265-36-0

      21-chloro-17α-hydroxy-16α-methylpregna-1,4,9(11)-triene-3,20-dione

    • 50-02-2
      50-02-2

      dexamethasone

  • Related Products

    • 17,21-dihydroxy-16alpha-methylpregna-1,4,9(11)-triene-3,20-dione

    • 17,21-dihydroxy-16alpha-methylpregna-1,4,9(11)-triene-3,20-dione

    • 17,21-dihydroxy-16alpha-methylpregna-1,4,9(11)-triene-3,20-dione

    • 17,21-dihydroxy-16alpha-methylpregna-1,4,9(11)-triene-3,20-dione

  • *Product Name
    CAS
    Purity
    Quantity
    Company name
    *Email
    *Other Description
    *Code
    The items marked with* are mandatory.
    Submit